Bredemarket

Who Took This Test?

(Imagen 3)

As a follow-up to “You Need a Driver’s License,” my latest wildebeest picture is called “Who Took This Test?”

If Tik Stops Tokking (in the U.S.)

Not that it’s authoritative, but I asked Google Gemini what may happen to TikTok users on Sunday, January 19. The text below was written by Gemini.

On Sunday, January 19th, 2025, if the current legal situation remains unchanged:

New users will not be able to download TikTok.

Existing users will likely still be able to use the app on their devices. However, the app will no longer receive updates or bug fixes, potentially leading to performance issues and security vulnerabilities over time.

Important Note: This is based on the current understanding of the legal proceedings. The situation could change if:

The Supreme Court intervenes: They could potentially block or delay the ban.

TikTok is sold: If TikTok is sold to an approved buyer, the ban may be lifted.

I recommend staying updated on the latest news and legal developments regarding this issue.

An Eventful Monday

Now that I’ve formally scheduled the release of my talkie—it’s even an “event” on Facebook—I may as well provide a description of what my talkie contains.

First, the video is 3 minutes and 40 seconds long, which for me is long. And why you won’t see it on Bluesky or Instagram. But you will see it here; it’s already scheduled.
Oh, and I talk. The video alternates between shots of me at Bredemarket world headquarters and shots of textual/image descriptions incorporating Canva’s finest AI-generated music. If you’ve seen my other videos you know the…um…score.
I start by introducing the subject of “marketing and writing services” and identifying MY hungry people (target audience).
Then I explain, in detail, what Bredemarket’s “CPA” services are NOT…and what they ARE.
I briefly touch on the questions I ask my clients. If you’ve read Bredemarket’s “Seven Questions Your Content Creator Will Ask You,” you’re already familiar with these questions.
Then I do something that some sales professionals would NEVER do—reveal my pricing up front.
Finally, my call to action is for interested prospects to book a meeting with me on my CPA page. If you don’t already have the link to that page, you’ll get it on Monday.

Well, that’s that. Come back Monday at 8:00 am Pacific Standard Time / 1600 GMT.

My Latest Bredemarket Video Is (well, will be) a Talkie

I assembled my latest video on Friday night.

It’s a talkie.

But my talkie doesn’t cause 21st century controversy.

I still have my usual text, images, and AI-generated music, but I actually talk between the segments.

I plan to release the video on Monday.

Well, except on Bluesky and other social channels that can’t handle 3 minute and 40 second long videos.

The facts are that I need to trim 2 minutes and 40 seconds to get my new video on Bluesky.

On a Bredemarket Instagram story shared Friday afternoon (to disappear Saturday), I noted Meta’s AI advice NOT to call someone who flew a drone near firefighting equipment an “idiot.” I respectfully disagree. The term is appropriate.

Let me clarify that Meta is not trying to curtail free speech. Only governments can curtail free speech. Private entities cannot.

For example, if I still worked for IDEMIA, and used IDEMIA social media channels to declare the Thales ABIS the best ABIS ever, IDEMIA has every right to delete that post—and me.

In the same way, if Zuck insists that Meta users cannot refer to people threatening lives as “idiots,” that is Meta’s right.

But it’s idiotic.

Proposal Tools of the 2020s

When I was last a full-time Proposal Manager a decade ago (for MorphoTrak), a proposal due date extension did not necessitate an update to an Asana task end date. Asana existed (its iOS and Android apps were both released by 2015), but MorphoTrak wasn’t using them.

Things are different now.

My consulting firm Bredemarket has helped (at least) four identity/biometric companies with proposal work over the years, including RFI responses, RFP responses, proposal letters, and similar communications; proposal templates; and proposal standard text (what the machinists call “boilerplate”).

I signed non-disclosure agreements with all these companies, which is why I redacted my current client’s name and its prospective customer from the accompanying image. But if my client wins, I will celebrate. Quietly.

Incidentally, since my Asana is only accessible to me, it only includes minimal information. In Asana, this entire response is a single entry. I use other means to communicate the more detailed schedule to my clients.

Incidentally, if you were one of MY prospects and received a communication saying that I was wrapping up a project today…I’m not. But it’s almost wrapped up, bearing in mind that any gas fills up the available space.

But if you want me to work on your gas, contact me via Bredemarket’s “CPA” page.

Proposal work (the P) is just one of several services Bredemarket provides to identity, biometric, and technology clients. In fact, all 4 of the referenced Proposal clients have also used my Content services, my Analysis services, or both.

CPA

NEC’s Other “Biometric” Information: Digital Pathology

(Image: AI-predicted cell detection results of Biomy’s DeepPathFinder™. From the January 10, 2025 NEC press release.)

When I interact with the worldwide company NEC, I am usually dealing with automated biometric identification systems (ABIS).

Of course, ABIS is only a small part of what NEC does. It’s also involved in healthcare.

Consider…artificial intelligence and deep learning-powered digital pathology (“a field involving the digitization and computational analysis of pathology slides”).

Per today’s press release:

“NEC Corporation (NEC; TSE: 6701) and Biomy, Inc. (Biomy) have signed a Memorandum of Understanding (MoU) for a joint marketing partnership to develop and expand artificial intelligence/deep learning (AI/DL)-based analytical platforms in the field of digital pathology. Through this partnership, the two companies aim to promote precision medicine for cancer patients and contribute to the advancement of the healthcare industry.”

So what is Biomy contributing?

“Biomy, which aims to realize personalized medicine through pathological AI technology, has developed DeepPathFinder™, a proprietary, cloud-based, AI/DL automated digital pathology analytical platform.”

And NEC?

“NEC has positioned healthcare and life sciences as a core pillar of its growth strategy. With a strong foundation in image analysis and other AI technologies, NEC has a long history of providing medical information systems such as electronic medical records to healthcare institutions.”

As I’ve said before, healthcare must deal with privacy concerns (protected health information, or PHI) similar to those NEC addresses in its other biometric product line (personally identifiable information, or PII). I personally can’t do nefarious things if I fraudulently acquire your digital pathology slide, but some bad actors could. Presumably the Biomy product is well protected.